|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/11 | |
| C12N 15/113 | |||
| A61K 31/712 |
| (11) | Patento numeris | 2742136 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12751399.2 |
| Europos patento paraiškos padavimo data | 2012-08-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-06-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/049989 |
| Data | 2012-08-08 |
| (87) | Numeris | WO 2013/022967 |
| Data | 2013-02-14 |
| (30) | Numeris | Data | Šalis |
| 201161522659 P | 2011-08-11 | US | |
| 201261596723 P | 2012-02-08 | US | |
| 201261603196 P | 2012-02-24 | US |
| (72) |
OESTERGAARD, Michael, US
PRAKASH, Thazha, P., US
SETH, Punit, P., US
SWAYZE, Eric, E., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | GAPPED OLIGOMERIC COMPOUNDS COMPRISING 5`-MODIFIED DEOXYRIBONUCLEOSIDES IN THE GAP AND USES THEREOF |
| GAPPED OLIGOMERIC COMPOUNDS COMPRISING 5`-MODIFIED DEOXYRIBONUCLEOSIDES IN THE GAP AND USES THEREOF |